Antisense Technology
New antisense technology research reported from Center for Cancer Research
Published in Gene Therapy Weekly, December 28th, 2006
Investigators publish new data in the report "Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough." According to recent research from the United States, "The class I major histocompatibility complex (MHC) receptors expressed by natural killer (NK) cells play an important role in regulating their function. The number and type of inhibitory receptors expressed by NK cells must be tightly controlled in order to avoid the generation of dominantly inhibited NK cells."
"The selective stochastic expression of the class I MHC receptors generates a variegated NK cell population capable of discriminating...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-28)
More Articles from Gene Therapy Weekly
- Chronic Lymphocytic Leukemia
Lentigen wins U.S. NIH grant to develop a potential new therapy for CLL - Sexual & Reproductive Health
Gene therapy for erectile dysfunction shows promise in clinical trial - Breast Cancer Therapy
University of Lubeck details research in breast cancer therapy - Cancer Gene Therapy
Investigators at University of Colorado, Colorado Cancer Center have published new data on cancer gene therapy - Cancer Gene Therapy
Korea Institute of Radiological and Medical Science details research in cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy research from Georgetown University, Lombardi Comprehensive Cancer Center outlined - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
